在试验中纳入服务不足群体:英国某基层医疗临床试验中心的审计
该审计评估牛津基层医疗临床试验中心2017至2023年间获批的19项试验对INCLUDE指南所列服务不足群体及《2010年英国平等法》受保护特征的纳入情况。常见排除涉及年龄、性别、语言、知情同意能力、妊娠、多种健康问题及疾病严重程度,许多明确排除可能并非必要,可能降低试验包容性并限制结果对外推人群的适用性。所有试验本可收集更具信息量的服务不足群体状态数据。
要点
- 审计纳入2017至2023年获批的19项试验,覆盖CTIMP与非CTIMP等多种干预类型。
- 常见排除包括年龄(19项)、疾病严重程度(17项)、知情同意能力(14项)等。
- 作者认为许多明确排除可能并非必要,可能降低包容性并限制结果适用性。
核心结论
- 许多明确排除可能并非必要,可能降低试验包容性并限制试验结果对相关人群的适用性。
- 作者指出所有试验本可收集更具信息量的服务不足群体状态数据。
研究设计与样本
- 该审计评估牛津基层医疗临床试验中心(PC-CTU)开展的试验对服务不足群体的纳入情况。
- 纳入2017至2023年间获得伦理批准的试验,共19项,涵盖CTIMP与非CTIMP及多种临床疾病和干预类型,多数为非商业资助。
- 审查了21份方案、29份患者信息单/ leaflet和40份数据收集工具,对照INCLUDE指南所列服务不足群体及《2010年英国平等法》受保护特征识别明确排除和数据收集情况。
主要发现
- 常见排除基于年龄(19项)、性别或社会性别(11项)、语言(8项)、知情同意能力(14项)、妊娠(11项)、多种健康问题(10项)和疾病严重程度(17项)。
- 试验最常收集的数据包括年龄(19项)、性别或社会性别(15项)、族裔(16项)、教育(11项)、地址(13项)、心理健康状况(6项)、谁给予知情同意(19项)、成瘾(6项)、多种健康问题(10项)、疾病严重程度(17项)、吸烟状态(12项)和肥胖(13项)。
临床怎么用
- 作者认为许多明确排除可能并非必要,可能降低试验包容性并限制结果适用性,包括排除18岁以下人群、英语不流利人群和无知情同意能力人群。
- 作者指出所有试验本可收集更具信息量的服务不足群体状态数据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical trials need to include patients who are representative of the population who may receive the tested interventions in the future. The importance of inclusivity is recognised by ethical and funding bodies and has public support. Appropriate inclusion is required to provide equitable evidence-based healthcare and to comply with ethical principles for research. However, there is little information about the inclusivity of most under-served groups in UK clinical trials. METHODS: This audit assesses the inclusion of under-served groups in trials run by the Oxford Primary Care Clinical Trials Unit (PC-CTU). We included trials with ethical approval between 2017 and 2023. We checked protocols, patient-facing information and selected data collection tools for information on the under-served groups in the INCLUDE guidance and protected characteristics in the UK Equality Act 2010, to identify explicit exclusions and data collection. RESULTS: We included 19 trials. They were in a variety of clinical conditions, testing different types of interventions, both Clinical Trial of an Investigational Medicinal Product (CTIMP) and non-CTIMP. Most were non-commercially funded. We reviewed 21 protocols, 29 Patient Information Sheets/Leaflets and 40 data collection tools. Common exclusions were based on age (19), sex or gender (11), language (8), capacity to consent (14), pregnancy (11), multiple health conditions (10) and severity of illness (17). Trials most often collected data on age (19), sex or gender (15), ethnicity (16), education (11), address (13), mental health conditions (6), who gave consent (19), addiction (6), multiple health conditions (10), severity of illness (17), smoking status (12) and obesity (13). CONCLUSIONS: Often, exclusions were due to the focusing of the trial for a specific group, such as older people, women, or people being treated for a specific severity of condition. However, many explicit exclusions may not have been essential, may have reduced the inclusivity of the trials and might limit the applicability of the trial's findings to people to whom the tested interventions might be relevant. These include the exclusion of people aged under 18, people without English language fluency and people without capacity to consent. All trials could have collected more informative data on under-served group status.
引用
- Burrow R, Carr M, Goddard L, et al. Inclusion of under-served groups in trials: an audit at a UK primary care clinical trials unit. Trials. 2025. PMID: 40544294. doi:10.1186/s13063-025-08893-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。